Quotes with Resistance & Support
Market Information

Buy RComm, target of Rs 350: Motilal Oswal

Posted on: June 2nd, 2009 and is filed under Brokerage Recommendations.

Motilal Oswal has maintained its buy rating on Reliance Communications with a target price of Rs 350 in its May 30, 2009 research report.

“RCOM is seeking shareholders’ approval to raise funds through equity/equity-linked instruments which could result in potential equity dilution of up to 25%. As per the company, the funds would enable it to strengthen its balance sheet and equip it to participate in the upcoming 3G/Wi-Max auctions. RCOM’s shareholders have approved the scheme of arrangement for demerger of RCOM’s optic fiber division to Reliance Infratel. RCOM and its subsidiaries hold 94.5% stake in Reliance Infratel, financial investors hold 5%, while employee welfare trust holds 0.5% stake. As per RCOM’s notice convened for shareholders’ meeting, net consideration for the transfer of optic fiber assets would be Rs 67.2 billion.”

“We are upgrading our March 10 target price to Rs 350 which now reflects nil discount to DCF (v/s 10% earlier) and incorporates a lower WACC of 12.8% v/s 13.5% earlier given reduced leverage concerns. Maintain ‘Buy’ on likely operational turnaround post recent GSM launch, and abating concerns on high leverage,” says Motilal Oswal’s research report.

Tags: , , , , , ,

Similar Posts:

Recent Posts

China, Hong Kong markets to trade on NSE from tomorrow. - Hang Seng ETF to list on the National Stock Exchange on Thursday. Indian investors will soon be able..
In Market News
No BTST possible today - Stocks bought today (15-03-10) cannot be sold tomorrow (16-03-10) - Kindly note that todays (15-03-10) cash market purchase cannot be sold for delivery tomorrow (16-03-..
In Market News
IL&FS Transportation, Pradip Overseas IPOs get huge subscriptions - The ongoing initial public offers (IPOs) are witnessing overwhelming response from investors with to..
In Market News
Patent dispute resolution, a booster for Ranbaxy - Ranbaxy Laboratories has firmed up after settling a patent dispute with Takeda Pharmaceutical Compan..
In Market News

Breakouts

+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

@ RAMUboth companies have posted huge loss in recent times.india foils as per rediff.com has posted ...view more »
- by Dr Jorawar
Status: Awaiting reply

Market Stats

  • Sensex
    17490.08
    +0.00
    [0.00%]
  • Nifty
    5231.90
    +33.80
    [+0.65%]
  • Dow Jones
    10733.67
    +47.69
    [+0.45%]
  • Nasdaq
    2389.09
    +11.08
    [+0.47%]
  • Dow Futures
    10733.00
    +7.00
    [+0.07%]
  • Nikkei 225
    10831.78
    -15.20
    [-0.14%]
  • Hang Seng
    21384.49
    +0.00
    [0.00%]
  • Straits Times
    2909.98
    -9.32
    [-0.32%]
  • Shanghai
    3050.89
    +0.41
    [+0.01%]
  • FTSE 100
    5644.63
    +24.20
    [+0.43%]
  • CAC 40
    3957.89
    +18.94
    [+0.48%]

Search Our Archives

Latest Investment Idea